At BCG, there is a true culture of innovation and research inherited from our founder Bruce Henderson. It is a true laboratory of ideas.
When I was young, I wavered between medical studies and a preparatory class for the so-called Grandes Écoles, between my taste for scientific research and my desire for operational work. At BCG, I could combine these two in my professional life. I am currently in charge of the Strategy practice for the Paris, Casablanca, and Tel Aviv offices, specializing in the biotech and health care topic—a fascinating field where you witness fundamental discoveries and where our clients face major business transformation challenges. I focus on the heart of scientific innovation and the new-growth prospects it induces and am fortunate enough to work with the whole ecosystem, from leading labs to innovative startups, investment funds, and universities. This provides me with unique insights into the complex issues of this business sector. For instance, we organized an event on genome editing in San Francisco with the participation of the world's most prominent experts, researchers, startups, and pharmaceutical companies.
Before joining BCG, I could not have imagined I would have reached such a level of responsibility as partner and managing director by the age of 32.
Elsy graduated from École Polytechnique in 2001. She was a core member of our Health Care practice.
Q: What do you like most about your job?
A: The relationships of trust we establish with our clients. We work in a spirit of co-construction to create true change and strong impact.
Q: How has BCG helped you grow and succeed?
A: Even today, not a day goes by in which I do not learn something new and do not make progress on one matter or another. This dynamic is based on the ceaseless challenges arising from our various case assignments, on the high level of professional relationships and training. We also acquire a lot of knowhow, without even being aware of it, merely by permeation.
Q: How has your network grown as part of BCG?
A: My professional network has grown and developed very quickly. Indeed, we interact on a regular basis with our clients, with whom I keep in touch; with institutional stakeholders of the health care industry; and with investment funds, research centers, and experts—in France, obviously, but also in Europe and the rest of the world.